UCFA
ABMD

United Capital Financial Advisors’s Abiomed Inc ABMD Stock Holding History

United Capital Financial Advisors’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-757
Closed -$216K – 1502
2019
Q1 		$216K Sell
757
-63
-8% -$20.9K ﹤0.01% 1247
2018
Q4 		$267K Buy
820
+137
+20% +$47.6K ﹤0.01% 1106
2018
Q3 		$307K Buy
683
+61
+10% +$24K ﹤0.01% 1100
2018
Q2 		$254K Buy
+622
New +$225K ﹤0.01% 1154

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
AAMU
Amundi Asset Management US Boston, Massachusetts $131B AUM 73.57% 1-Year Est. Return

United Capital Financial Advisors's ABMD Position: Q2 2019 in Review

United Capital Financial Advisors sold out of Abiomed Inc (ABMD) in Q2 2019, closing a stake of 757 shares — an estimated $216K sold.

United Capital Financial Advisors first reported a position in ABMD in Q2 2018 and held it in 4 quarters. The position peaked at $307K in Q3 2018. 484 funds tracked by Wall St. Rank hold ABMD as of Q2 2019.

  • United Capital Financial Advisors reported no remaining Abiomed Inc position as of Q2 2019 after selling out during the quarter.
  • United Capital Financial Advisors sold 757 Abiomed Inc shares in Q2 2019, an estimated $216K.
  • United Capital Financial Advisors first reported a position in Abiomed Inc in Q2 2018 and held it in 4 quarters.
  • United Capital Financial Advisors's Abiomed Inc position peaked at $307K in Q3 2018.
  • 484 funds tracked by Wall St. Rank held Abiomed Inc as of Q2 2019.

Based on United Capital Financial Advisors's 13F filing for Q2 2019, filed 13 Aug 2019.